Solid oral formulation used for treating gastrointestinal motility disorders such as irritable bowel syndrome comprises acid sensitive active agent and disintegrant

摘要

Solid oral pharmaceutical composition comprises an acid sensitive active agent or active agent which is poorly soluble in aqueous media and a disintegrant present in at least 15 wt.% based on the total weight of the composition. An Independent claim is included for a 5-HT4 receptor agonist or partial agonist used as or in the manufacture of a veterinary pharmaceutical.